559 related articles for article (PubMed ID: 29731168)
1. Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.
Cho SW; Xu J; Sun R; Mumbach MR; Carter AC; Chen YG; Yost KE; Kim J; He J; Nevins SA; Chin SF; Caldas C; Liu SJ; Horlbeck MA; Lim DA; Weissman JS; Curtis C; Chang HY
Cell; 2018 May; 173(6):1398-1412.e22. PubMed ID: 29731168
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract][Full Text] [Related]
3. C-Myc-activated long non-coding RNA PVT1 enhances the proliferation of cervical cancer cells by sponging miR-486-3p.
Wang C; Zou H; Chen A; Yang H; Yu X; Yu X; Wang Y
J Biochem; 2020 Jun; 167(6):565-575. PubMed ID: 31943014
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis.
Jin K; Wang S; Zhang Y; Xia M; Mo Y; Li X; Li G; Zeng Z; Xiong W; He Y
Cell Mol Life Sci; 2019 Nov; 76(21):4275-4289. PubMed ID: 31309249
[TBL] [Abstract][Full Text] [Related]
5. p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis.
Olivero CE; Martínez-Terroba E; Zimmer J; Liao C; Tesfaye E; Hooshdaran N; Schofield JA; Bendor J; Fang D; Simon MD; Zamudio JR; Dimitrova N
Mol Cell; 2020 Feb; 77(4):761-774.e8. PubMed ID: 31973890
[TBL] [Abstract][Full Text] [Related]
6. Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.
Riquelme E; Suraokar MB; Rodriguez J; Mino B; Lin HY; Rice DC; Tsao A; Wistuba II
J Thorac Oncol; 2014 Jul; 9(7):998-1007. PubMed ID: 24926545
[TBL] [Abstract][Full Text] [Related]
7. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer.
Shigeyasu K; Toden S; Ozawa T; Matsuyama T; Nagasaka T; Ishikawa T; Sahoo D; Ghosh P; Uetake H; Fujiwara T; Goel A
Mol Cancer; 2020 Nov; 19(1):155. PubMed ID: 33148262
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA PVT1 acts as an oncogenic driver in human pan-cancer.
You Z; Xu S; Pang D
J Cell Physiol; 2020 Nov; 235(11):7923-7932. PubMed ID: 31957871
[TBL] [Abstract][Full Text] [Related]
9. LncRNA PVT1 promotes bladder cancer progression by forming a positive feedback loop with STAT5B.
Li Z; Fu H; Liu J; Song W; Zeng M; Wang J
Pathol Res Pract; 2023 Aug; 248():154635. PubMed ID: 37392551
[TBL] [Abstract][Full Text] [Related]
10. lncRNA PVT1 promotes hepatitis B virus‑positive liver cancer progression by disturbing histone methylation on the c‑Myc promoter.
Jiang B; Yang B; Wang Q; Zheng X; Guo Y; Lu W
Oncol Rep; 2020 Feb; 43(2):718-726. PubMed ID: 31894346
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA
Handa H; Honma K; Oda T; Kobayashi N; Kuroda Y; Kimura-Masuda K; Watanabe S; Ishihara R; Murakami Y; Masuda Y; Tahara KI; Takei H; Kasamatsu T; Saitoh T; Murakami H
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992461
[TBL] [Abstract][Full Text] [Related]
12. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus.
Xiang JF; Yin QF; Chen T; Zhang Y; Zhang XO; Wu Z; Zhang S; Wang HB; Ge J; Lu X; Yang L; Chen LL
Cell Res; 2014 May; 24(5):513-31. PubMed ID: 24662484
[TBL] [Abstract][Full Text] [Related]
13. LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3/Slug axis and epithelial-to-mesenchymal transition in gastric cancer.
Zhao J; Wu J; Qin Y; Zhang W; Huang G; Qin L
Cell Oncol (Dordr); 2020 Oct; 43(5):863-876. PubMed ID: 32729021
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1.
Shen SN; Li K; Liu Y; Yang CL; He CY; Wang HR
Mol Oncol; 2019 Dec; 13(12):2554-2573. PubMed ID: 31369196
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion.
Wang Y; Zhou J; Wang Z; Wang P; Li S
Biochem Biophys Res Commun; 2017 Nov; 493(1):429-436. PubMed ID: 28882595
[TBL] [Abstract][Full Text] [Related]
17. A pan-cancer analysis of MYC-PVT1 reveals CNV-unmediated deregulation and poor prognosis in renal carcinoma.
Posa I; Carvalho S; Tavares J; Grosso AR
Oncotarget; 2016 Jul; 7(30):47033-47041. PubMed ID: 27366943
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
Zhao J; Du P; Cui P; Qin Y; Hu C; Wu J; Zhou Z; Zhang W; Qin L; Huang G
Oncogene; 2018 Jul; 37(30):4094-4109. PubMed ID: 29706652
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
[TBL] [Abstract][Full Text] [Related]
20. MYC and PVT1 synergize to regulate RSPO1 levels in breast cancer.
Sarver AL; Murray CD; Temiz NA; Tseng YY; Bagchi A
Cell Cycle; 2016; 15(7):881-5. PubMed ID: 26889781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
